GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,039,000 | +6.3% | 92,713 | +7.6% | 0.16% | +0.6% |
| Q4 2021 | $3,799,000 | +12.4% | 86,138 | -2.6% | 0.16% | -5.3% |
| Q3 2021 | $3,381,000 | -3.5% | 88,477 | +0.6% | 0.17% | -3.4% |
| Q2 2021 | $3,503,000 | +11.2% | 87,975 | -0.4% | 0.18% | +2.9% |
| Q1 2021 | $3,150,000 | -99.9% | 88,287 | -4.1% | 0.17% | -13.6% |
| Q4 2020 | $3,389,331,000 | +33.6% | 92,101 | +36.7% | 0.20% | +20.0% |
| Q3 2020 | $2,536,761,000 | +82476.9% | 67,395 | -10.5% | 0.16% | +358.3% |
| Q2 2020 | $3,072,000 | +11.4% | 75,310 | +3.5% | 0.04% | -40.0% |
| Q1 2020 | $2,757,000 | -55.9% | 72,770 | -45.3% | 0.06% | -53.5% |
| Q4 2019 | $6,248,000 | -17.3% | 132,964 | -24.9% | 0.13% | -29.1% |
| Q3 2019 | $7,553,000 | -18.2% | 176,957 | -23.3% | 0.18% | -23.2% |
| Q2 2019 | $9,239,000 | -14.9% | 230,850 | -11.2% | 0.24% | -63.3% |
| Q1 2019 | $10,863,000 | +2.1% | 259,935 | -6.7% | 0.64% | -10.5% |
| Q4 2018 | $10,643,000 | -2.7% | 278,541 | +2.3% | 0.72% | +944.9% |
| Q3 2018 | $10,938,000 | -3.3% | 272,302 | -2.9% | 0.07% | -2.8% |
| Q2 2018 | $11,309,000 | +7.8% | 280,554 | +4.5% | 0.07% | -88.4% |
| Q1 2018 | $10,494,000 | +234.4% | 268,601 | +203.6% | 0.61% | +182.0% |
| Q4 2017 | $3,138,000 | -24.4% | 88,477 | -13.5% | 0.22% | -26.4% |
| Q3 2017 | $4,152,000 | +2.4% | 102,266 | +8.8% | 0.30% | -6.6% |
| Q2 2017 | $4,054,000 | +14.5% | 94,008 | +11.9% | 0.32% | +15.8% |
| Q1 2017 | $3,541,000 | +32.0% | 83,991 | +20.5% | 0.27% | +18.7% |
| Q4 2016 | $2,683,000 | +35.8% | 69,681 | +43.0% | 0.23% | +10.6% |
| Q1 2016 | $1,976,000 | +10.9% | 48,731 | +10.4% | 0.21% | +13.0% |
| Q4 2015 | $1,781,000 | -21.3% | 44,138 | -25.0% | 0.18% | -25.2% |
| Q3 2015 | $2,263,000 | +198.9% | 58,859 | +223.6% | 0.25% | +105.0% |
| Q2 2015 | $757,000 | +68.6% | 18,187 | +116.4% | 0.12% | +50.0% |
| Q4 2013 | $449,000 | -1.5% | 8,406 | -7.5% | 0.08% | -1.2% |
| Q3 2013 | $456,000 | +1.3% | 9,087 | +1.0% | 0.08% | -12.0% |
| Q2 2013 | $450,000 | – | 8,998 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |